Myostatin antibodies are monoclonal or polyclonal immunoglobulins that bind to myostatin (growth differentiation factor 8, GDF8), a member of the TGF-β superfamily encoded by the MSTN gene . By neutralizing myostatin, these antibodies block its interaction with activin type IIB receptors (ActRIIB), thereby preventing downstream signaling pathways that limit muscle growth .
Myostatin antibodies exert dual effects on muscle homeostasis:
Pathway | Effect of Myostatin Inhibition | Outcome |
---|---|---|
Akt/mTORC1 Signaling | Restores protein synthesis | Hypertrophy (muscle fiber enlargement) |
Ubiquitin Ligases | Reduces FoxO-mediated protein degradation | Decreased muscle atrophy |
Satellite Cell Activation | Enhances proliferation and differentiation | Improved muscle regeneration |
For example, GYM329, a novel antibody, binds the latent form of myostatin and employs "sweeping antibody technology" to clear myostatin from muscles and plasma . This approach outperforms conventional antibodies by enhancing both specificity and efficacy .
Duchenne Muscular Dystrophy (DMD): Preclinical studies in mdx mice showed a 15–25% increase in muscle mass and improved grip strength with anti-myostatin antibodies .
Spinal Muscular Atrophy (SMA):
Apitegromab: In a Phase II trial (NCT03921528), nonambulatory SMA patients receiving 20 mg/kg apitegromab + nusinersen showed improved Hammersmith Functional Motor Scale (HFMSE) scores .
Taldefgrobep alfa: RESILIENT trial (NCT05156320) includes ambulant and nonambulatory SMA patients, with results expected in late 2024 .
A 4-week treatment with ATA 842 in aged mice (23 months) increased lean mass by 10% and improved insulin sensitivity .
GYM329 increased muscle mass in cynomolgus macaques by 12% without toxicity .
PF-354 (anti-myostatin antibody) improved in situ muscle strength in 21-month-old mice after 14 weeks .
Myostatin, also known as Growth Differentiation Factor 8 (GDF-8), is a member of the Transforming Growth Factor-beta (TGF-β) superfamily. It plays a crucial role in regulating skeletal muscle growth by inhibiting muscle differentiation and growth. The Myostatin Polyclonal Rabbit Anti-Human Antibody is a valuable tool in research for detecting and studying myostatin in various biological samples.
Myostatin is a secreted protein that negatively regulates muscle growth. It is synthesized as a precursor protein that undergoes proteolytic processing to produce a mature, biologically active form. The mature myostatin protein contains seven conserved cysteine residues, which are characteristic of the TGF-β superfamily. Myostatin is expressed predominantly in skeletal muscle tissues and has been shown to play a role in muscle homeostasis and development.
Polyclonal antibodies are a mixture of immunoglobulin molecules secreted against a specific antigen, each recognizing a different epitope. They are produced by immunizing an animal (in this case, a rabbit) with the target antigen (myostatin). The animal’s immune system generates a diverse array of antibodies, which are then collected from the serum. Polyclonal antibodies are advantageous because they recognize multiple epitopes on the target antigen, increasing the likelihood of successful detection.
The production of the Myostatin Polyclonal Rabbit Anti-Human Antibody involves several steps:
The Myostatin Polyclonal Rabbit Anti-Human Antibody is used in various research applications, including: